Results 81 to 90 of about 20,045 (250)

The first live term birth following uterus transplantation in Australia

Medical Journal of Australia, EarlyView.
Abstract Objective To report the first live birth following uterus transplantation in Australia. Study design Case report. Setting, participant The first participant in the uterus transplantation research study program at the Royal Hospital for Women, the Prince of Wales Hospital, and Westmead Hospital in Sydney.
Rebecca Deans, Brigitte Gerstl, Antonia W Shand, Sarah Lyons, Aaron Budden, Helen L Barrett, Grant Luxton, Mangalee Fernando, Kenneth Yong, Karen Keung, Kaushalya Arulpragasam, Henry Pleass, King Man Wan, Eva Kehag, Jana‐Emily Pittman, Mianna Lotz, Maria Fenn, Erin Nesbitt‐Hawes, Lily Byun, Katrina Tang, Mats Brannstrom, Jason Abbott   +21 more
wiley   +1 more source

Environmental Risk Factors for Pneumocystis Pneumonia Hospitalizations in HIV Patients [PDF]

, 2012
Background. Pneumocystis pneumonia (PcP) is the second leading cause of morbidity and mortality in human immunodeficiency virus (HIV)–infected patients in the United States.
Djawe, K, Fong, S, Grieco, K, Huang, L, Jarlsberg, L, Levin, L, Miller, RF, Roth, B, Subramanian, A, Swartzman, A, Walzer, PD   +10 more
core   +1 more source

Invasive Fungal Infections in Orthotopic Heart Transplant Patients: Incidence and Risk Factors in the Modern Era

Clinical Transplantation, Volume 39, Issue 8, August 2025.
ABSTRACT Background Invasive fungal infections (IFI) post‐orthotopic heart transplant (OHT) have not been well studied due to limited information in large databases. The goal of the study is to describe the incidence and risk factors for IFI. Methods In this retrospective cohort study, we analyzed risk factors associated with IFI among OHT recipients ...
Lana Hasan, Lalithaa Thirunavukarasu Murugan, Eileen Hsich, Michael Zhen‐Yu Tong, Kyle D. Brizendine   +4 more
wiley   +1 more source

Virtual Screening of Phytochemicals to Novel Target (HAT) Rtt109 in Pneumocystis Jirovecii using Bioinformatics Tools [PDF]

Journal of Clinical and Diagnostic Research, 2016
Introduction: Pneumocystis jirovecii is a fungus that causes Pneumocystis pneumonia in HIV and other immunosuppressed patients. Treatment of Pneumocystis pneumonia with the currently available antifungals is challenging and associated with ...
Ramya Sugumar, Abhinand Ponneri Adithavarman, Anusha Dakshinamoorthi, Darling Chellathai David, Padmavathi Kannan Ragunath   +4 more
doaj   +1 more source

Debates in Management and Treatment of CMV in Pediatric Solid Organ Transplant Recipients: A Case‐Based Discussion

Pediatric Transplantation, Volume 29, Issue 5, August 2025.
ABSTRACT The recently published 4th International Consensus Guidelines on the Management of CMV in Solid‐Organ Transplantation offers updated recommendations for CMV prevention, treatment, and monitoring in pediatric solid organ transplant (pSOT) recipients.
Kevin J. Downes, Lara Danziger‐Isakov, Gustavo Varela‐Fascinetto, Betsy C. Herold, Michael Green, Arnaud G. L'Huillier   +5 more
wiley   +1 more source

Designing an mRNA Vaccine against P. jirovecii Involved in Fatal Pneumonia Infections via Comparative Proteomics and Reverse Vaccinology Approaches

Frontiers in Bioscience-Landmark
Background: Pneumocystis jirovecii is the most emerging life-threating health problem that causes acute and fatal pneumonia infection. It is rare and more contagious for patients with leukemia and immune-deficiency disorders.
Muhammad Naveed, Khizra Jabeen, Tariq Aziz, Muhammad Saad Mughal, Hammad Arif, Metab Alharbi, Thamer H Albakeiri, Abdullah F. Alasmari   +7 more
doaj   +1 more source

New Short Tandem Repeat-Based Molecular Typing Method for Pneumocystis jirovecii Reveals Intrahospital Transmission between Patients from Different Wards.

PLoS ONE, 2015
Pneumocystis pneumonia is a severe opportunistic infection in immunocompromised patients caused by the unusual fungus Pneumocystis jirovecii. Transmission is airborne, with both immunocompromised and immunocompetent individuals acting as a reservoir for ...
Maud Gits-Muselli, Marie-Noelle Peraldi, Nathalie de Castro, Véronique Delcey, Jean Menotti, Nicolas Guigue, Samia Hamane, Emmanuel Raffoux, Anne Bergeron, Sandrine Valade, Jean-Michel Molina, Stéphane Bretagne, Alexandre Alanio   +12 more
doaj   +1 more source

Elranatamab for Relapsed/Refractory Multiple Myeloma With Severe Renal Impairment Requiring Hemodialysis

Hematological Oncology, Volume 43, Issue 4, July 2025.
ABSTRACT Relapsed/refractory multiple myeloma (RRMM) patients with dialysis‐dependent renal impairment face limited therapeutic options due to exclusion from clinical trials, a lack of evidence‐based guidelines, and inferior outcomes. Bispecific antibodies targeting B‐cell maturation antigen (BCMA) have shown promise in RRMM treatment but remain ...
Michèle Hoffmann, Barbara Jeker, Uyen Huynh‐Do, Yara Banz, Jeanne Godau, Elisabeth Weber, Ulrike Bacher, Thomas Pabst   +7 more
wiley   +1 more source

Genotypic variation in Pneumocystis jirovecii isolates in Britain [PDF]

Thorax, 2005
Pneumocystis jirovecii is the cause of Pneumocystis pneumonia (PCP) in immunosuppressed humans. Asymptomatic colonisation with P jirovecii may occur in patients with minor immunosuppression or chronic lung disease. The aim of this study was to describe the molecular epidemiology of P jirovecii in Britain over a period of 12.5 years.Between January 1989
Miller, RF, Lindley, AR, Copas, A, Ambrose, HE, Davies, RJO, Wakefield, AE   +5 more
openaire   +4 more sources

Interhuman Transmission as a Potential Key Parameter for Geographical Variation in the Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Mutations [PDF]

, 2017
Background. Pneumocystis jirovecii dihydropteroate synthase (DHPS) mutations are associated with failure of prophylaxis with sulfa drugs. This retrospective study sought to better understand the geographical variation in the prevalence of these mutations.
Bille, Jacques, Francioli, Patrick, Hauser, Philippe M., Nahimana, Aimable, Rabodonirina, Meja, Taffe, Patrick, Weber, Rainer   +6 more
core